Position Statement: Pert Shortage

Pancreatic enzyme replacement therapy (PERT) shortage – advice for the management of adults with pancreatic exocrine insufficiency

Position Statement: Pancreatic enzyme replacement therapy (PERT) shortage – advice for the management of adults with pancreatic exocrine insufficiency
Phillips M.E1,3, McGeeney L.M1, Watson K-L2, Lowdon J2.

Position statement and advice for prescribers and patients from the 1Nutrition Interest Group of the Pancreatic Society of Great Britain and Ireland (NIGPS), 2 Cystic Fibrosis Specialist Group and 3 Gastroenterology Specialist Group, British Dietetic Association.
Endorsed by the British Society of Gastroenterology (Pancreas section); Pancreatic Society of Great Britain and Ireland, Pancreatic Cancer UK, GUTS UK, Cystic Fibrosis Trust, CF Medical Association and the British Dietetic Association.
Issue date: 26th March 2024 (Version 1)

Please ensure you are reading the most up to date version.

Follow this link below to download the resource